Brief: China Regenerative Medicine International Posts Profit For Year Attributable Hk$13.3 Million

China Regenerative Medicine International

31/03/2022 16:15

March 31 (Reuters) - China Regenerative Medicine
International Ltd  8158.HK :
    * PROFIT FOR YEAR ATTRIBUTABLE HK$13.3 MILLION VERSUS LOSS
OF
HK$404.2 MILLION
    * FY REVENUE FROM CONTINUING OPERATIONS HK$282.9 MILLION
VERSUS
HK$185.3 MILLION

Source text for Eikon:  ID:nHKS4ZZJnW 
Further company coverage:  8158.HK 

 ((Reuters.Briefs@thomsonreuters.com;))